EPO grants second CRISPR patent to ERS Genomics – Life Sciences Intellectual Property Review
Life Sciences Intellectual Property Review |
EPO grants second CRISPR patent to ERS Genomics
Life Sciences Intellectual Property Review The European Patent Office (EPO) has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT's patent relating to the technology. ERS Genomics announced the EPO's approval of … |
